Studying CBD
No Result
View All Result
  • Home
  • CBD
  • About CBD
  • What is CBD
  • Home
  • CBD
  • About CBD
  • What is CBD
No Result
View All Result
Studying CBD
No Result
View All Result
Home What is CBD

Clever Leaves heads to UK to target burgeoning CBD market

Peter F. by Peter F.
October 5, 2019
in What is CBD
39 0
0
Clever Leaves heads to UK to target burgeoning CBD market
32
SHARES
358
VIEWS
Share on TwitterShare on Facebook

[ad_1]

Clever Leaves has an area of 15 hectares under active cultivation in Colombia, which will rise to 25ha by the end of this year.

believes that its control of the process from planting, product development through to marketing will help it stand out in the burgeoning cannabis and hemp-derived products space.

The Colombian group’s co-founder and chief executive Andrés Farjado told Proactive its operations allow it to know exactly from which seed shelf a product comes, enabling it to impose strict quality controls.

“We control the whole process. We control the whole chain and we focus on our quality and innovation.” 

“We are offering a great standard of product.

“And that uniqueness of being able to control the value chain is going to be very appealing both to consumers and to physicians and patients on the pharmaceutical side.”

has an area of 15 hectares under active cultivation in Colombia, which will rise to 25ha by the end of this year.

That acreage will put it into the world’s top three for installed growing capability.

WATCH: Clever Leaves to launch its first consumer CBD product in the UK next week

Set up in 2016, staff numbers now total around 500 and Fajades has his sights firmly set on expanding into Europe.

“We have three business lines,” he says.

A B2B business supplies ingredients such as cannabis extracts, distillates or isolates under licence to other product makers.

also makes a range of white-labelled products.

Second, is the pharmaceutical arm where products need to be recommended by a doctor.

The company is working with doctors in Germany to refine its products for specific indications and also to get EU certification for the production of pharmaceutical grades.

RELATED  The gray area: CBD is still technically illegal in Iowa. So why do so many stores in the Quad-Cities sell it? | Local Crime & Courts

Finally, Fajades sees huge potential in a range of wellness offerings containing CBD oils.

A range of cannabis and hemp-derived products launched this week in the UK, which Fajades believes leads the world market currently for CBD products as a lifestyle choice.

Here again, Fajades believes control of the supply chain gives it an advantage.

“To guarantee high-quality reliable products, we have to deliver the CBD that we say we are putting in -which blend of plant it came from when it was extracted and formulated.”

To control the smell as well so that it has the right appeal you also need the right terpene (scent essence) profile, says Fajades.

If all goes well, Clever Leaves will have sold a hundred thousand products in the UK by Christmas though Fajades says that is more of an indication than a hard target.

Clever Leaves will have a better idea once the first results following the launch are available.

The UK will be the testbed for future wellness product launches over the next 12-18 months and eventually be the launch-pad for a push into Europe.

Germany, meanwhile, will be the proving ground for pharmaceutical products development. 

This will involve an education process about the therapeutic benefits of cannabis and the benefits and types of products it will be able to launch once it receives EU certification.

“We are a cannabis company focused on adding value and generating revenues”.

[ad_2]

Source link

Tweet8Share13Share3Share
Peter F.

Peter F.

We study the effects of cannabidiol (CBD), a non-psychoactive component of cannabis that does not produce the high associated with smoking or using it."There is a lot of debate on the health effects of marijuana and the use of cannabinoids, which are a group of compounds found in marijuana that have anti-inflammatory, pain-relieving, anti-nausea and anti-emetic properties. However, there is a lack of solid scientific evidence to guide us in the application of cannabis therapeutics."

No Result
View All Result
  • Privacy Policy
  • Contact
  • About us

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.. For more information contact Info@sdmediagrp.comContinuePrivacy policy